These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9871512)

  • 1. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.
    Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Bioorg Med Chem Lett; 1998 Apr; 8(8):913-8. PubMed ID: 9871511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of chloromethyl ketone derivatives for selective human chymase inhibitors.
    Hayashi Y; Iijima K; Katada J; Kiso Y
    Bioorg Med Chem Lett; 2000 Feb; 10(3):199-201. PubMed ID: 10698435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones.
    Akahoshi F; Ashimori A; Yoshimura T; Imada T; Nakajima M; Mitsutomi N; Kuwahara S; Ohtsuka T; Fukaya C; Miyazaki M; Nakamura N
    Bioorg Med Chem; 2001 Feb; 9(2):301-15. PubMed ID: 11249123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
    Niwata S; Fukami H; Sumida M; Ito A; Kakutani S; Saitoh M; Suzuki K; Imoto M; Shibata H; Imajo S; Kiso Y; Tanaka T; Nakazato H; Ishihara T; Takai S; Yamamoto D; Shiota N; Miyazaki M; Okunishi H; Kinoshita A; Urata H; Arakawa K
    J Med Chem; 1997 Jul; 40(14):2156-63. PubMed ID: 9216834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2397-401. PubMed ID: 11078187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
    Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
    Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic difluoromethylene ketones as novel inhibitors of human chymase.
    Akahoshi F; Ashimori A; Sakashita H; Yoshimura T; Eda M; Imada T; Nakajima M; Mitsutomi N; Kuwahara S; Ohtsuka T; Fukaya C; Miyazaki M; Nakamura N
    J Med Chem; 2001 Apr; 44(8):1297-304. PubMed ID: 11312928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma.
    Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2403-6. PubMed ID: 11078188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.
    Llinàs-Brunet M; Bailey M; Fazal G; Ghiro E; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2267-70. PubMed ID: 11055335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
    Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
    Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA investigations on two series of artificial peptide inhibitors of the serine protease thermitase. Synthesis of an inhibitor of predicted greater potency.
    Brandt W; Lehmann T; Willkomm C; Fittkau S; Barth A
    Int J Pept Protein Res; 1995 Jul; 46(1):73-8. PubMed ID: 7558600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate.
    Johnson LA; Moon KE; Eisenberg M
    Biochim Biophys Acta; 1988 Apr; 953(3):269-79. PubMed ID: 2451541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of human heart chymase based on a peptide library.
    Bastos M; Maeji NJ; Abeles RH
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6738-42. PubMed ID: 7624313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptidic chymase inhibitors: design and structure-activity relationships of pyrimidinone derivatives based on the predicted binding mode of a peptidic inhibitor.
    Akahoshi F
    Curr Pharm Des; 2003; 9(15):1191-9. PubMed ID: 12769746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.